Cooperative Agreement for a Prescriber s Clinical Support System for the Appropriate Use of Opioids in the Treatment of Pain and Opioid related Addiction | Apply Online

Opportunity Information: Apply for TI 11 007

• The Substance Abuse Mental Health Services Adminis. in the health sector is offering a public funding opportunity titled "Cooperative Agreement for a Prescriber s Clinical Support System for the Appropriate Use of Opioids in the Treatment of Pain and Opioid related Addiction" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.243 Substance Abuse and Mental Health ServicesProjects of Regional and National Significance.
• This funding opportunity was created on Mar 9, 2011 and posted on Mar 9, 2011.
• Applicants must submit their applications by Apr 19, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2024.)
• The funding agency has allocated a total of $500,000.00 to eligible and selected applicants.
• Each selected applicant is eligible to receive up to $500,000.00 in funding.
• The number of recipients for this funding is limited to 1 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
• There is a serious public health issue involving the abuse, misuse, non medical use and concomitant morbidity and mortality associated with the increased availability of opioids for the treatment of acute pain, chronic pain and opioid related addiction. While these medications are obtained through theft and other forms of diversion, SAMHSA surveys indicate that opioids used non medically are usually obtained through prescriptions. The Federal Controlled Substance Act permits physicians (including specialties such as psychiatrists, osteopaths, family practice, etc.), mid level practitioners (such as nurse practitioners and physicians assistants), dentists, and other health professionals, to register to prescribe and dispense controlled opioid medications for the treatment of pain, and in limited cases, dependence. Collectively, the quantity of these controlled opioids prescribed by physicians, dentists, and others, has increased several fold over the last decade. There are concerns that opioid prescribing practices may be contributing to the availability of opioid analgesics in the illicit market. In addition, SAMHSA recognizes the difficulty in assessing patients for appropriate opioid prescribing and the limited training that physicians, psychiatrists, and dentists may receive during their formal, specialized training. Moreover, licensed physicians and dentists, who have completed their formal training, lack adequate mentoring, continuing medical education, and other resources to evaluate patients and prescribe opioid analgesics appropriately. To address this public health problem in a timely manner, SAMHSA is limiting eligibility for this cooperative agreement to the American Society of Addiction Medicine, the American Academy of Addiction Psychiatry, the American Medical Association, the American Osteopathic Association, the American Psychiatric Association, and the American Dental Association. These organizations have extensive experience in providing educational and other support services to their members. As such, SAMHSA believes they are uniquely qualified to meet the requirements outlined in this announcement because they have the experience, infrastructure and capacity in place to expeditiously begin program activities. Any of these entities may apply individually they may also apply as a consortium comprised of all or several of the eligible organizations. If a consortium is formed for this purpose, a single organization in the consortium must be the legal applicant, the recipient of the award, and the entity legally responsible for satisfying the grant requirements. If a consortium submits an application, the application must include a written agreement outlining the roles and responsibilities of each organization participating in the consortium. This agreement must be signed by an authorized official of each member of the consortium and attached to the application in Attachment 3 of the RFA, Roles and Responsibilities of Participating Consortium Organizations.

Apply for TI 11 007

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: